WBR0768: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
YazanDaaboul (talk | contribs)
Bots, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, oversight, smwadministrator, Administrators, Widget editors
9,960 edits
No edit summary
YazanDaaboul (talk | contribs)
Bots, Bureaucrats, bureaucrats, editnews, exportpages, interwiki, nocaptcha, nukepages, oversight, smwadministrator, Administrators, Widget editors
9,960 edits
No edit summary
Line 21: Line 21:
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=Pulmonology, General Principles
|SubCategory=Pulmonology, General Principles
|Prompt=A 27-year-old woman is brought to the emergency department (ED) with severe abdominal pain and nausea. Her temperature is 36.8 °C (98.24 °F), heart rate is 88/min, and blood pressure is 128/78 mmHg. Her husband arrives to the ED shortly and informs the physician that the patient attempted to commit suicide and ingested more than 20 tables of acetaminophen 5 hours before admission. The physician decides to administer a drug to reduce the effect of acetaminophen toxicity. What is another indication for the same drug that is used to manage this patient's condition?
|Prompt=A 27-year-old woman is brought to the emergency department (ED) with severe abdominal pain and nausea. Her temperature is 36.8 °C (98.24 °F), heart rate is 88/min, and blood pressure is 128/78 mmHg. Her husband arrives to the ED shortly and informs the physician that the patient attempted suicide and ingested more than 20 tables of acetaminophen 5 hours before admission. The physician promptly administers an antioxidant drug that regenerates glutathione and reduces the effect of acetaminophen toxicity. The administered drug is also indicated to manage which condition?
|Explanation=The patient is presenting with acetaminophen (paracetamol) toxicity. When patients present late, awaiting the serum levels of acetaminophen is not be very helpful, and administration of N-acetylcysteine prior to the return of serum concentration of acetaminophen is necessary. Symptoms of acetaminophen overdose are generally non-specific, and typical manifestations include abdominal pain and nausea. N-acetylcysteine is an anti-oxidant that regenerates glutathione and reduces the generation of toxic reactive oxygen species (ROS). It is used to reduce the effect of acetaminophen (paracetamol) toxicity. N-acetylcysteine is also a mucolytic that is usually used to manage patients with cystic fibrosis.
|Explanation=The patient is presenting with acetaminophen (paracetamol) toxicity. When patients with acetaminophen toxicity present late, it is not necessary to wait for the the serum concentration of acetaminophen, and administration of N-acetylcysteine prior to the return of serum concentration of acetaminophen is necessary. Symptoms of acetaminophen overdose are generally non-specific, and typical manifestations include abdominal pain and nausea. N-acetylcysteine is an antioxidant that regenerates glutathione and reduces the generation of toxic reactive oxygen species (ROS). It is used to reduce the effect of acetaminophen (paracetamol) toxicity. In addition, N-acetylcysteine is a mucolytic agent that is usually used to manage mucus plugging in patients with cystic fibrosis and chronic obstructive pulmonary disease (COPD).
|AnswerA=Mucolysis
|AnswerA=Mucus plugging
|AnswerAExp=N-acetylcysteine is a mucolytic agent that is frequently used to manage patients with cystic fibrosis (CF)
|AnswerAExp=N-acetylcysteine is an antioxidant and mucolytic agent that is frequently used to manage mucus plugging in patients with cystic fibrosis and COPD.
|AnswerB=Nasal congestion
|AnswerB=Nasal congestion
|AnswerBExp=N-acetylcysteine is not a decongestant.
|AnswerBExp=N-acetylcysteine is not a decongestant.
Line 33: Line 33:
|AnswerE=Gastoesophageal reflux disease (GERD)
|AnswerE=Gastoesophageal reflux disease (GERD)
|AnswerEExp=N-acetylcysteine is not generally used to treat GERD.
|AnswerEExp=N-acetylcysteine is not generally used to treat GERD.
|EducationalObjectives=N-acetylcysteine reduces the effect of acetaminophen (paracetamol) toxicity. It is mucolytic agent used to manage patients with cystic fibrosis.
|EducationalObjectives=N-acetylcysteine is an antioxidant and mucolytic agent that is frequently used to manage mucus plugging in patients with cystic fibrosis and COPD.
|References=Sadowska AM, Verbraecken J, Darquennes K, et al. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(4):425-34.<br>
First Aid 2014 page 88, 252
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=acetaminophen, paracetamol, toxicity, overdose, suicide, attempt, commit, N-acetylcysteine, acetylcysteine, antidote, glutathione, regeneration, repletion, depletion, reactive, oxygen, species, mucolysis, mucolytic, cystic, fibrosis
|WBRKeyword=Acetaminophen, Paracetamol, Toxicity, Overdose, Suicide, N-acetylcysteine, Acetylcysteine, COPD, Antioxidant, Antidote, Glutathione, Reactive oxygen species, Mucolysis, Cystic fibrosis
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 16:59, 9 March 2015
Author [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::Pulmonology, SubCategory::General Principles
Prompt [[Prompt::A 27-year-old woman is brought to the emergency department (ED) with severe abdominal pain and nausea. Her temperature is 36.8 °C (98.24 °F), heart rate is 88/min, and blood pressure is 128/78 mmHg. Her husband arrives to the ED shortly and informs the physician that the patient attempted suicide and ingested more than 20 tables of acetaminophen 5 hours before admission. The physician promptly administers an antioxidant drug that regenerates glutathione and reduces the effect of acetaminophen toxicity. The administered drug is also indicated to manage which condition?]]
Answer A AnswerA::Mucus plugging
Answer A Explanation AnswerAExp::N-acetylcysteine is an antioxidant and mucolytic agent that is frequently used to manage mucus plugging in patients with cystic fibrosis and COPD.
Answer B AnswerB::Nasal congestion
Answer B Explanation AnswerBExp::N-acetylcysteine is not a decongestant.
Answer C AnswerC::Exercise-induced asthma
Answer C Explanation AnswerCExp::N-acetylcysteine is not generally used to treat exercise-induced asthma.
Answer D AnswerD::Bronchoconstriction
Answer D Explanation AnswerDExp::N-acetylcysteine is not generally used to treat bronchoconstriction.
Answer E AnswerE::Gastoesophageal reflux disease (GERD)
Answer E Explanation AnswerEExp::N-acetylcysteine is not generally used to treat GERD.
Right Answer RightAnswer::A
Explanation [[Explanation::The patient is presenting with acetaminophen (paracetamol) toxicity. When patients with acetaminophen toxicity present late, it is not necessary to wait for the the serum concentration of acetaminophen, and administration of N-acetylcysteine prior to the return of serum concentration of acetaminophen is necessary. Symptoms of acetaminophen overdose are generally non-specific, and typical manifestations include abdominal pain and nausea. N-acetylcysteine is an antioxidant that regenerates glutathione and reduces the generation of toxic reactive oxygen species (ROS). It is used to reduce the effect of acetaminophen (paracetamol) toxicity. In addition, N-acetylcysteine is a mucolytic agent that is usually used to manage mucus plugging in patients with cystic fibrosis and chronic obstructive pulmonary disease (COPD).

Educational Objective: N-acetylcysteine is an antioxidant and mucolytic agent that is frequently used to manage mucus plugging in patients with cystic fibrosis and COPD.
References: Sadowska AM, Verbraecken J, Darquennes K, et al. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(4):425-34.
First Aid 2014 page 88, 252]]

Approved Approved::Yes
Keyword WBRKeyword::Acetaminophen, WBRKeyword::Paracetamol, WBRKeyword::Toxicity, WBRKeyword::Overdose, WBRKeyword::Suicide, WBRKeyword::N-acetylcysteine, WBRKeyword::Acetylcysteine, WBRKeyword::COPD, WBRKeyword::Antioxidant, WBRKeyword::Antidote, WBRKeyword::Glutathione, WBRKeyword::Reactive oxygen species, WBRKeyword::Mucolysis, WBRKeyword::Cystic fibrosis
Linked Question Linked::
Order in Linked Questions LinkedOrder::
Retrieved from "https://www.wikidoc.org/index.php?title=WBR0768&oldid=1076316"